查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2018648

靜脈輸液幫浦市場：全球市場按產品類型、技術、便攜性、最終用途和應用進行預測 - 2026-2032年

Intravenous Infusion Pump Market by Product Type, Technology, Portability, End Use, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，靜脈輸液幫浦市場價值將達到 53.6 億美元，到 2026 年將成長至 59.2 億美元，到 2032 年將達到 105.6 億美元，年複合成長率為 10.17%。

主要市場統計數據
基準年 2025 53.6億美元
預計年份：2026年 59.2億美元
預測年份 2032 105.6億美元
複合年成長率 (%) 10.17%

簡要概述了重新定義現代醫療保健環境中靜脈輸液幫浦部署的臨床、技術和操作因素。

靜脈輸液幫浦已從單純的床邊設備轉變為現代臨床工作流程的核心組成部分，影響著急診護理、門診診療和家庭護理計畫的方方面面。本文總結了促使醫療系統重新思考其輸液策略、安全規程和採購方式的技術、臨床和營運因素。此外，本文也探討了漸進式設計改進、軟體驅動控制以及互通性提升如何共同增強輸液幫浦在藥物檢驗安全方面的作用。

改進的設計如何優先考慮連接性和安全性、擴大分散式護理以及注重監管，從而共同加速輸液泵策略的發展？

靜脈輸液幫浦領域正經歷著一場變革性的轉型，其驅動力包括數位科技的成熟、對病人安全日益重視以及不斷演進的醫療服務模式的協同效應。智慧技術正滲透到產品藍圖，設備也正從獨立儀器轉變為互聯臨床生態系中的節點。這一演變強調減少錯誤邏輯、實現即時數據流的無線連接以及改進人機互動介面，從而減輕床邊操作人員的認知負荷。

本文探討了 2025 年關稅修訂對輸液幫浦供應生態系統內的採購選擇、供應鏈彈性策略和資本配置的影響。

2025年美國實施的關稅調整所帶來的累積影響，顯著增加了輸液幫浦相關人員的採購計畫和供應鏈韌性的複雜性。進口關稅的提高和分類規則的修訂，導致部分零件和成品的接收成本上升，迫使採購團隊重新評估供應商多元化、生產地點以及總體擁有成本（TCO）分析。為此，採購部門加快了供應商選擇流程的完善和緊急時應對計畫的製定，以降低關稅波動帶來的風險。

從詳細的細分觀點展示了最終使用環境、產品類型、技術水準、應用要求和便攜性等方面的差異如何影響設備需求。

從細分市場觀點分析靜脈輸液幫浦市場，可以發現不同的需求促進因素和部署模式會因臨床環境和產品架構的差異而有所差異。依最終用途分類，不同環境的需求趨勢也各不相同：門診手術中心優先考慮快速安裝和周轉率；居家照護環境則更注重易用性和可靠性，尤其適合非專業看護者；而醫院環境則需要更高級的功能和整合能力，以實現集中監測。按產品類型分類，注射式幫浦通常適用於小劑量、精準輸注的應用場景，例如新生兒和兒童護理；而容量幫浦則適用於更廣泛的輸注方案，需要更大的輸注量、更高的精確度和多參數程式功能。

採購重點、管理體制和醫療服務模式的區域差異如何影響輸液設備的區域部署模式？

區域趨勢對靜脈輸液技術的採購選擇、監管路徑和部署速度有顯著影響。在美洲，醫療系統和門診網路優先考慮能夠與現有電子健康記錄互通性並具備完善的上市後監測能力的設備。同時，商業性和報銷的考量也促使企業採購那些能夠展現營運效率和安全性的解決方案。在歐洲、中東和非洲，由於管理體制的差異和投資環境的波動，導致部署進度呈現出碎片化的特徵。一些市場優先考慮在醫院系統中經過驗證的可靠性和可維護性，而其他市場則專注於經濟高效、攜帶式的解決方案，以擴大醫療服務的覆蓋範圍。

對輸液設備供應商的競爭定位、夥伴關係策略和服務導向差異化進行評估，以確定其長期競爭優勢。

老牌製造商、專業設備製造商和新興參與企業之間的競爭動態正在重塑輸液設備市場的策略競爭優勢。主要企業正利用整合軟體平台、延長服務合約和臨床證據項目，使其產品在硬體之外脫穎而出。這些策略提高了同質化設備的進入門檻，同時也為那些能夠整合完善的文件、可擴展的支援網路和檢驗的互通性的公司創造了機會。

製造商和醫療保健系統面臨的可操作的策略挑戰，旨在加速安全部署、增強供應鏈韌性，並透過服務和證據實現差異化。

在不斷發展的輸液幫浦市場中，產業領導企業應優先採取一系列切實可行的措施，以增強臨床部署、保障供應彈性並實現商業性差異化。首先，他們必須使產品藍圖與互通性標準保持一致，投資於檢驗的減少錯誤功能和無線連接，以減輕臨床醫生的負擔並實現設備管理。同時，網路安全和軟體生命週期管理實務必須滿足日益嚴格的監管要求，從而維護醫療IT和風險管理相關人員之間的信任。

本報告的見解得到了透明、多方面的研究框架的支持，該框架結合了相關人員訪談、監管分析和第二手資料檢驗。

本研究採用多方面方法，結合對主要相關人員的訪談、監管文件的審查以及對相關二手資訊的整合，以確保獲得平衡且基於證據的見解。關鍵資訊來源包括與臨床醫生、採購負責人、生物醫學工程師和供應鏈經理的對話，以揭示營運挑戰、臨床需求和採購考慮。對監管和標準文件的系統性審查也揭示了在設備開發和部署實踐中體現的關於安全性、網路安全和互通性的不斷變化的期望。

我們透過前瞻性的綜合分析來指導採購和產品策略，重點在於設備創新、供應彈性和臨床整合的融合。

總之，靜脈輸液幫浦領域正處於一個轉折點，其特點是技術整合、醫療服務模式的轉變以及監管和採購力度的加強。將可靠的硬體與檢驗的軟體功能、完善的服務模式以及在地化支援相結合的醫療設備，將最能滿足現代醫療服務提供者的複雜需求。其部署趨勢不僅取決於功能特性，還取決於製造商能否證明其臨床價值、確保網路安全，並提供適用於門診、家庭和醫院環境的靈活採購和服務模式。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 靜脈輸液幫浦市場：依產品類型分類

  • 注射式幫浦
  • 容積式泵

第9章 靜脈輸液幫浦市場：依技術分類

  • 智慧泵浦
    • 劑量誤差減少系統
    • 無線連線
  • 傳統的

第10章：靜脈輸液幫浦市場－攜帶式

  • 可攜式的
    • 交流電源
    • 電池供電
  • 固定式

第11章 靜脈輸液幫浦市場：依最終用途分類

  • 門診手術中心
  • 居家照護
  • 醫院

第12章 靜脈輸液幫浦市場：依應用領域分類

  • 麻醉
  • 經腸營養
  • 新生兒醫學
  • 腫瘤學
  • 疼痛管理
  • 兒童

第13章 靜脈輸液幫浦市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 靜脈輸液幫浦市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 靜脈輸液幫浦市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國靜脈輸液幫浦市場

第17章：中國靜脈輸液幫浦市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Advanced Instrumentations, Inc.
  • Arcomed AG
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • CODAN Medizinische Gerate GmbH & Co KG
  • Fresenius Kabi AG
  • Hospira, Inc.
  • ICU Medical, Inc.
  • InfuSystem Holdings, Inc.
  • IRadimed Corporation
  • JMS Co., Ltd.
  • KD Scientific, Inc.
  • Medima Sp. z oo
  • Mindray Medical International Limited
  • Moog Inc.
  • Nipro Corporation
  • Plenum Tech Pvt. Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Smiths Group plc
  • Terumo Corporation
  • Zyno Medical, Inc.
Product Code: MRR-22146147702D

The Intravenous Infusion Pump Market was valued at USD 5.36 billion in 2025 and is projected to grow to USD 5.92 billion in 2026, with a CAGR of 10.17%, reaching USD 10.56 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.36 billion
Estimated Year [2026] USD 5.92 billion
Forecast Year [2032] USD 10.56 billion
CAGR (%) 10.17%

A concise orientation to the clinical, technological, and operational forces redefining intravenous infusion pump adoption across modern care delivery settings

The intravenous infusion pump has transitioned from a discrete bedside device into a focal point of contemporary clinical workflows, with implications that reach across acute care, ambulatory services, and home-based therapy programs. This introduction synthesizes the technological, clinical, and operational drivers that are prompting healthcare systems to reevaluate infusion strategies, safety protocols, and procurement approaches. It examines how incremental design improvements, software-enabled controls, and interoperability ambitions collectively elevate the role of pumps in medication administration safety.

Clinical teams now expect infusion solutions to do more than maintain fluid delivery; they must also integrate with electronic medication administration records, support dosing safeguards, and enable analytics that inform quality-improvement initiatives. At the same time, healthcare providers are balancing capital stewardship with a growing need for devices that reduce human error, shorten training time, and support decentralized care models such as home infusion and ambulatory procedural units. Regulatory scrutiny and payer-driven quality measures amplify the importance of demonstrable safety features and traceability.

Throughout this introduction, the intent is to orient readers to the principal forces shaping device selection and utilization, to frame the critical trade-offs encountered by clinicians and purchasing leaders, and to set the stage for subsequent sections that dive into shifting market dynamics, tariff impacts, segmentation nuances, regional patterns, and actionable recommendations for stakeholders seeking to navigate a complex, innovation-driven environment.

How connectivity, safety-driven design upgrades, decentralized care expansion, and regulatory focus are jointly accelerating evolution in infusion pump strategies

The landscape for intravenous infusion pumps is undergoing transformative shifts driven by a confluence of digital maturation, heightened patient safety priorities, and evolving care delivery models. Smart technologies are penetrating product roadmaps, moving devices from stand-alone instruments toward nodes in a connected clinical ecosystem. This evolution emphasizes dose error reduction logic, wireless connectivity for real-time data flows, and improved human-machine interfaces that reduce cognitive load at the bedside.

Simultaneously, health systems are reallocating care pathways to accommodate more procedures outside the inpatient setting, which is increasing demand for portable pump variants that are robust, user-friendly, and suitable for home infusion management. Manufacturers are responding with design changes that prioritize battery efficiency, ergonomic handling, and simplified programming to meet both clinician and patient expectations. These shifts carry operational implications: procurement teams must weigh lifecycle costs, training burdens, and compatibility with existing electronic health record infrastructures.

Regulatory authorities and accreditation bodies are also reinforcing requirements for traceability and incident reporting, pushing suppliers to strengthen cybersecurity postures and software validation processes. Transitioning care models, combined with technological modernization and regulatory pressure, are reordering competitive advantages and compelling legacy suppliers to accelerate innovation cycles while ensuring interoperability and demonstrable clinical value.

An exploration of how 2025 tariff revisions reshaped procurement choices, supply chain resilience tactics, and capital allocation within infusion pump supply ecosystems

The cumulative impact of tariff changes in the United States during 2025 introduced material complexity into procurement planning and supply chain resilience for infusion pump stakeholders. Increased import duties and revised classification rulings elevated landed costs for some components and finished devices, prompting purchasing teams to reassess supplier diversity, production footprints, and total cost of ownership analyses. Procurement groups responded by amplifying supplier qualification processes and accelerating contingency planning to mitigate exposure to customs-related volatility.

Manufacturers evaluated options ranging from nearshoring assembly operations to redesigning bill-of-materials where feasible to avoid tariff-sensitive categories. These responses required capital reallocation and timeline adjustments for product roadmaps, often introducing trade-offs between immediate cost mitigation and long-term strategic investments in R&D. In parallel, distributors and hospital supply chains adjusted inventory policies, increasing safety stock for critical devices and components while balancing storage costs and obsolescence risks.

Clinicians and materials managers observed operational ripple effects: purchasing delays or cost pressures sometimes postponed planned technology refreshes, and tighter margin environments accelerated conversations about rental, managed-service, and-as-a-service procurement models. Ultimately, tariff-driven shifts in 2025 reinforced the need for transparent supplier agreements, scenario-based procurement playbooks, and cross-functional coordination between regulatory, clinical, and supply chain teams to maintain continuity of care and device safety standards.

A nuanced segmentation-driven perspective demonstrating how end-use settings, product types, technology tiers, application needs, and portability distinctions shape device requirements

Examining the intravenous infusion pump market through a segmentation lens reveals differentiated demand drivers and nuanced adoption patterns across clinical contexts and product architectures. Based on End Use, demand dynamics vary between Ambulatory Surgical Center environments that prioritize rapid set-up and turnover, Home Care settings where simplicity and reliability for non-professional caregivers are paramount, and Hospital environments demanding advanced features and integration capabilities for intensive monitoring. Based on Product Type, syringe pumps typically address low-volume, targeted delivery use cases such as neonatal and pediatric care, while volumetric pumps serve broader infusion regimens that require higher-volume precision and multi-parameter programming.

Considerations based on Technology distinguish Smart Pump offerings, which incorporate Dose Error Reduction System functionality and wireless connectivity that enable closed-loop safety checks and remote fleet management, from Traditional pumps that emphasize mechanical reliability and straightforward operation. Based on Application, the clinical use cases influence feature prioritization: anesthesia and oncology applications often require high-precision dosing and compatibility with anesthesia workstations or chemotherapy protocols, whereas enteral nutrition, pain management, neonatology, and pediatrics impose their own distinct safety and usability constraints. Based on Portability, stationary systems are favored in controlled inpatient areas for continuous high-volume therapies, while portable options-available in AC Operated and Battery Operated variants-serve ambulatory, transport, and home infusion scenarios where mobility and battery life are critical.

These segmentation perspectives illuminate how different customer cohorts prioritize distinct value propositions. Product development roadmaps and go-to-market strategies that align device attributes with specific end-use, technological expectations, application requirements, and portability needs will be better positioned to achieve clinical acceptance and operational integration across diverse care settings.

How geographic differences in procurement priorities, regulatory regimes, and care delivery models are directing regional adoption patterns for infusion devices

Regional dynamics materially influence procurement preferences, regulatory pathways, and adoption velocities for infusion technologies. In the Americas, health systems and outpatient networks place a premium on devices that support interoperability with established electronic health records and demonstrate robust post-market surveillance capabilities, while commercial and reimbursement considerations steer procurement toward solutions that can show operational efficiencies and safety outcomes. In Europe, Middle East & Africa, heterogeneous regulatory regimes and variable investment climates lead to a mosaic of adoption timelines; some markets prioritize proven reliability and serviceability in hospital systems, while others focus on cost-effective portable solutions to expand access to care.

Across Asia-Pacific, rapid expansion of ambulatory services and home-care programs is driving interest in portable, battery-operated devices and localized service networks that can support scaling use. Regional supply chain considerations also vary: some areas offer incentives for local manufacturing or assembly, whereas others rely heavily on established import channels. Interregional collaboration on standards and interoperability is improving, yet fragmentation persists, requiring manufacturers to adopt flexible regulatory and commercial approaches that respect local certification requirements and clinical preferences.

Taken together, regional insights emphasize the importance of adaptable product portfolios and region-specific support models. Manufacturers and health providers that align device features, training programs, and service logistics with the priorities of each geographic cluster will reduce friction in deployment and accelerate clinical acceptance.

An assessment of competitive positioning, partnership strategies, and service-oriented differentiation that determines long-term advantage for infusion device providers

Competitive dynamics among established manufacturers, specialist device firms, and emerging entrants are reshaping where strategic advantage resides in the infusion device landscape. Leading companies are leveraging integrated software platforms, extended-service agreements, and clinical evidence programs to differentiate offerings beyond hardware. These strategies are creating higher barriers to entry for commoditized devices while opening opportunities for firms that can pair robust documentation with scalable support networks and validated interoperability.

Partnerships between device makers, software vendors, and healthcare providers are maturing, producing bundled solutions that incorporate device fleets, analytics dashboards, and clinical decision-support enhancements. This trend is increasing the importance of lifecycle servicing as a revenue and retention lever, with extended warranties, training programs, and remote monitoring services becoming differentiators. Newer entrants often focus on niche clinical segments or disruptive form factors-such as ultra-portable battery-operated pumps-targeting under-served care settings where incumbents have less established penetration.

Market participants that excel at translating clinical outcomes and workflow efficiencies into credible value propositions tend to secure longer-term institutional relationships. The competitive trajectory favors companies that invest in interoperability, regulatory compliance, and robust post-market surveillance, while those that neglect software integrity or service reliability face escalating clinical and commercial resistance.

Practical strategic imperatives for manufacturers and health systems to accelerate safe adoption, strengthen supply resilience, and differentiate through service and evidence

Industry leaders should prioritize a set of actionable moves to fortify clinical adoption, supply resilience, and commercial differentiation in the evolving infusion pump landscape. First, align product roadmaps with interoperability standards and invest in validated dose error reduction features and wireless connectivity to reduce clinician burden and enable fleet management. Concurrently, ensure cybersecurity and software lifecycle practices meet rising regulatory expectations, thereby maintaining trust among healthcare IT and risk-management stakeholders.

Second, adopt flexible supply strategies that combine diversified sourcing, nearshoring where practical, and options for managed-service delivery to mitigate cost and tariff volatility. Strengthening service networks and offering modular training programs will reduce deployment friction in hospitals, ambulatory centers, and home care environments. Third, focus commercial efforts on articulating measurable clinical and operational benefits rather than hardware specifications alone; case studies and real-world evidence that demonstrate reduced medication incidents, shortened training times, or improved bed throughput will resonate with purchasing committees.

Finally, pursue partnerships with clinical leaders and payers to pilot innovative delivery models and reimbursement frameworks. These collaborations can accelerate acceptance of novel portable and software-enabled solutions by aligning stakeholder incentives and producing the evidence necessary to support broader institutional adoption.

A transparent multi-method research framework that combines stakeholder interviews, regulatory analysis, and secondary validation to underpin the report's insights

This research is grounded in a multi-method approach combining primary stakeholder interviews, regulatory documentation review, and targeted secondary-source synthesis to ensure balanced, evidence-based insights. Primary inputs included conversations with clinicians, procurement officers, biomedical engineers, and supply chain managers to surface operational pain points, clinical requirements, and purchasing considerations. Regulatory and standards documents were systematically reviewed to identify evolving safety, cybersecurity, and interoperability expectations that inform device development and deployment practices.

Secondary-source synthesis involved analyzing peer-reviewed clinical literature, white papers from professional societies, and manufacturer technical documentation to contextualize technical capabilities and clinical use cases. Where possible, real-world implementation case studies were examined to illustrate how hospitals and ambulatory services navigated integration and training challenges. Methodological safeguards included triangulation across data sources and the application of conservative interpretation where findings diverged, ensuring that conclusions reflect corroborated patterns rather than isolated anecdotes.

Analytical frameworks emphasized segmentation lenses-end use, product type, technology, application, and portability-paired with regional overlays to illuminate how device attributes interact with clinical contexts. The combination of qualitative stakeholder insight and document-based validation provides a robust foundation for the strategic recommendations and regional observations contained in this report.

A forward-looking synthesis highlighting the convergence of device innovation, supply resilience, and clinical integration that will guide procurement and product strategy

In conclusion, the intravenous infusion pump domain is at an inflection point defined by technological integration, shifting care delivery patterns, and heightened regulatory and procurement scrutiny. Devices that marry reliable hardware with validated software capabilities, strong service models, and regionally appropriate support structures will be best positioned to meet the complex needs of modern healthcare providers. Adoption trajectories will be influenced not only by feature sets but also by the ability of manufacturers to demonstrate clinical value, ensure cybersecurity, and offer flexible procurement and servicing models that suit ambulatory, home, and hospital environments.

Supply chain pressures and policy changes have underscored the importance of resilient sourcing and transparent commercial agreements, while segmentation and regional nuances highlight the necessity of tailored product portfolios. For stakeholders evaluating infusion strategies, the path forward involves prioritizing interoperability, investing in clinician-centered design, and fostering cross-functional collaboration across clinical, IT, and procurement teams to translate device capabilities into measurable safety and operational outcomes.

The findings assembled here are intended to guide product strategy, procurement decision-making, and clinical adoption planning, equipping leaders with a synthesis of the forces shaping this critical medical device category and a pragmatic blueprint for action.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intravenous Infusion Pump Market, by Product Type

  • 8.1. Syringe Pump
  • 8.2. Volumetric Pump

9. Intravenous Infusion Pump Market, by Technology

  • 9.1. Smart Pump
    • 9.1.1. Dose Error Reduction System
    • 9.1.2. Wireless Connectivity
  • 9.2. Traditional

10. Intravenous Infusion Pump Market, by Portability

  • 10.1. Portable
    • 10.1.1. Ac Operated
    • 10.1.2. Battery Operated
  • 10.2. Stationary

11. Intravenous Infusion Pump Market, by End Use

  • 11.1. Ambulatory Surgical Center
  • 11.2. Home Care
  • 11.3. Hospital

12. Intravenous Infusion Pump Market, by Application

  • 12.1. Anesthesia
  • 12.2. Enteral Nutrition
  • 12.3. Neonatology
  • 12.4. Oncology
  • 12.5. Pain Management
  • 12.6. Pediatrics

13. Intravenous Infusion Pump Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Intravenous Infusion Pump Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Intravenous Infusion Pump Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Intravenous Infusion Pump Market

17. China Intravenous Infusion Pump Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Advanced Instrumentations, Inc.
  • 18.6. Arcomed AG
  • 18.7. B. Braun Melsungen AG
  • 18.8. Baxter International Inc.
  • 18.9. Becton, Dickinson and Company
  • 18.10. Boston Scientific Corporation
  • 18.11. CODAN Medizinische Gerate GmbH & Co KG
  • 18.12. Fresenius Kabi AG
  • 18.13. Hospira, Inc.
  • 18.14. ICU Medical, Inc.
  • 18.15. InfuSystem Holdings, Inc.
  • 18.16. IRadimed Corporation
  • 18.17. JMS Co., Ltd.
  • 18.18. KD Scientific, Inc.
  • 18.19. Medima Sp. z o.o.
  • 18.20. Mindray Medical International Limited
  • 18.21. Moog Inc.
  • 18.22. Nipro Corporation
  • 18.23. Plenum Tech Pvt. Ltd.
  • 18.24. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 18.25. Smiths Group plc
  • 18.26. Terumo Corporation
  • 18.27. Zyno Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTRAVENOUS INFUSION PUMP MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES INTRAVENOUS INFUSION PUMP MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA INTRAVENOUS INFUSION PUMP MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SYRINGE PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SYRINGE PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SYRINGE PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY VOLUMETRIC PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY VOLUMETRIC PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY VOLUMETRIC PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SMART PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SMART PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SMART PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SMART PUMP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DOSE ERROR REDUCTION SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DOSE ERROR REDUCTION SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY DOSE ERROR REDUCTION SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY WIRELESS CONNECTIVITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY WIRELESS CONNECTIVITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY WIRELESS CONNECTIVITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY TRADITIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY TRADITIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY TRADITIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY AC OPERATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY AC OPERATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY AC OPERATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY BATTERY OPERATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY BATTERY OPERATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY BATTERY OPERATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY STATIONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY ANESTHESIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY ANESTHESIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY ENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY ENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY ENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY NEONATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY NEONATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY NEONATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SMART PUMP, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SMART PUMP, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SMART PUMP, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SMART PUMP, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE INTRAVENOUS INFUSION PUMP MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SMART PUMP, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE INTRAVENOUS INFUSION PUMP MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE INTRAVENOUS INFUSION PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST INTRAVENOUS INFUSION PUMP MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SMART PUMP, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST INTRAVENOUS INFUSION PUMP MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST INTRAVENOUS INFUSION PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SMART PUMP, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SMART PUMP, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SMART PUMP, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN INTRAVENOUS INFUSION PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. GCC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GCC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. GCC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. GCC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SMART PUMP, 2018-2032 (USD MILLION)
  • TABLE 144. GCC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 145. GCC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 146. GCC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 147. GCC INTRAVENOUS INFUSION PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION INTRAVENOUS INFUSION PUMP MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SMART PUMP, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION INTRAVENOUS INFUSION PUMP MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION INTRAVENOUS INFUSION PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SMART PUMP, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS INTRAVENOUS INFUSION PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. G7 INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. G7 INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 INTRAVENOUS INFUSION PUMP MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. G7 INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SMART PUMP, 2018-2032 (USD MILLION)
  • TABLE 168. G7 INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 169. G7 INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 170. G7 INTRAVENOUS INFUSION PUMP MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 171. G7 INTRAVENOUS INFUSION PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. NATO INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. NATO INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NATO INTRAVENOUS INFUSION PUMP MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. NATO INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SMART PUMP, 2018-2032 (USD MILLION)
  • TABLE 176. NATO INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 177. NATO INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 178. NATO INTRAVENOUS INFUSION PUMP MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 179. NATO INTRAVENOUS INFUSION PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL INTRAVENOUS INFUSION PUMP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES INTRAVENOUS INFUSION PUMP MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SMART PUMP, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES INTRAVENOUS INFUSION PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA INTRAVENOUS INFUSION PUMP MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY SMART PUMP, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA INTRAVENOUS INFUSION PUMP MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)